Already a member? Sign in
What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.
Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.
How - Joining Inspire is completely free and usually takes less than a minute. Join now!
I just saw on the ABC nightly news a blurb about a new drug that is working well with both breast and ovarian cancers that have previously been resistant to other drugs. I didn't get the name or all the details, so if interested, you can probably go to ABC's website.
Hi i saw it too.Its a PARP inhibitor called Olaparib(AZD2281)for BRCA 1 2 positive ovca.Its made by astra zeneca.its supposed to work in 2/3 of patients tested.I looked and there is not a lot of trials going on but a few places in the us.Most seems to be overseas in the UK.Keep Positive.
Hi, is it only for BRCA 1-2 positive women?
My hubby works for another pharm company that is developing a similar drug to work in conjunction with the one from Astra Zenaca. He is VERY excited about it's potential. It has been tested on a few end-stage ovca patients and the results have been extremely good.
The drug is called PARP inhibitors which kills cancer cells and could be ready in 1-2 years. Hang in there, ladies! This article published in the New England Journal of Medicine is creating great excitement. You can read about it below:
http://www.msnbc.msn.com/id/31512315/ns/health-womens_health/
Blessings and hugs!!!
Hello,
Herebelow a relevant link
http://news.bbc.co.uk/2/hi/health/8116790.stm
GEPI
I read something about this somewhere! Fantastic news.
Thanks,
Lynda
Add to the discussion